DeFronzo, Ralph A.
Norton, Luke
Abdul-Ghani, Muhammad
Article History
First Online: 12 December 2016
Competing interests
: R.A.D. has consulted for AstraZeneca, Janssen, and Boehringer Ingelheim, is a member of the Speaker's Bureau for AstraZeneca and Novo Nordisk, and has received grant support from AstraZeneca, Janssen, and Boehringer Ingelheim. His salary is supported in part by the South Texas Veterans Health Care System. The other authors declare no competing interests.